Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMZVDLS)

• Drug Name: NOX 2149 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Pain	MG30-MG3Z	Investigative	[1]
Stress	6B40-6B45	Investigative	[1]

• Cross-matching ID: TTD Drug ID: DMZVDLS

Molecule-Related Drug Atlas

Drug(s) Targeting Nociceptin receptor (OPRL1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMX-53	DMZUAJ4	Atopic dermatitis	EA80	Phase 2	[2]
SER-100	DMDW5ZC	Heart failure	BD10-BD13	Phase 2	[3]
BTRX-246040	DMA9238	Major depressive disorder	6A70.3	Phase 2	[4]
LY-2940094	DMB5L6Q	Major depressive disorder	6A70.3	Phase 2	[5]
NOCICEPTIN	DMUPA7C	Headache	8A80-8A84	Phase 1	[6]
JTC-801	DMV3UN4	Pain	MG30-MG3Z	Discontinued in Phase 2	[7]
ND1251	DMMLESX	Depression	6A70-6A7Z	Discontinued in Phase 1	[8]
ATI-17000	DMZJVR5	Irritable bowel syndrome	DD91.0	Preclinical	[9]
4-phenyl-1-(1-phenylbutyl)piperidin-4-ol	DMVCIJB	Discovery agent	N.A.	Investigative	[10]
1-(dio-tolylmethyl)-4-phenylpiperidin-4-ol	DMLYO8P	Discovery agent	N.A.	Investigative	[10]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Nociceptin receptor (OPRL1)	TTNT7K8	OPRX_HUMAN	Not Available	[1]

References

• [1] Therapeutic applications of aptamers. Expert Opin Investig Drugs. 2008 Jan;17(1):43-60.
• [2] Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activity. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5088-92.
• [3] Clinical pipeline report, company report or official report of Serodus ASA.
• [4] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [5] Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs. Biochemical Pharmacology Volume 95, Issue 2, 15 May 2015, Pages 81-97.
• [6] Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. J Pharmacol Exp Ther. 1997 Nov;283(2):735-41.
• [7] Nociceptin receptor antagonist JTC-801 inhibits nitrous oxide-induced analgesia in mice. J Anesth. 2009;23(2):301-3.
• [8] The nociceptin receptor as a potential target in drug design. Drug News Perspect. 2001 Aug;14(6):335-45.
• [9] Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection. Peptides. 2008 Dec;29(12):2257-65.
• [10] Bioorg Med Chem Lett. 2007 Jun 1;17(11):3023-7. Epub 2007 Mar 23.Synthesis and structure-activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 1.